Olmesartan or Pravastatine Trial on pre-metabolic syndrome

Olmesartan or Pravastatine Trial on pre-metabolic syndrome - Hokusetsu Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001454

Enrollment

Registered

2010-04-01

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive or Dyslipidemic patients

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1)Hypertensive and/or diabetic male patients who understand the study procedures using explanatory notes and have given written informed consent to participate in the study and 2)Patients have not yet received Olmesartan and Pravastatine.

Exclusion criteria

Exclusion criteria: 1)Contraindications of Olmesartan 2)Contraindications of Pravastatine

Design outcomes

Primary

Measure	Time frame
Changes of waist circumference, glucose-lipid metabolic parameters, and blood pressure, postprandial TBARS	—

Countries

Japan

Contacts

Public ContactKen Kishida

Osaka University Metabolic medicine

kkishida@imed2.med.osaka-u.ac.jp

Outcome results